Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy

Bibliography

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30
   PubMed Web of Science ®Google Scholar
• Merdan T, Kopecek J, Kissel T. Prospects for cationic polymers in gene and oligonucleotide therapy against cancer. Adv Drug deliv Rev 2002;54:715-58
   PubMed Web of Science ®Google Scholar
• Stribling R, Brunette E, Liggitt D, et al. Aerosol gene delivery in vivo. Proc Natl Acad Sci USA 1992;89:11277-81
   PubMed Web of Science ®Google Scholar
• Brain JD, Valberg PA. Deposition of aerosol in the respiratory tract. Am Rev Respir Dis 1979;120:1325-73
   PubMed Web of Science ®Google Scholar
• Koehler DR, Hitt MM, Hu J. Challenges and strategies for cystic fibrosis lung gene therapy. Mol Ther 2001;4:84-91
   PubMed Web of Science ®Google Scholar
• Cai K, Sham M, Tam P, et al. Lung cancer gene therapy. Gene Ther Mol Biol 2003;7:255-72
   Google Scholar
• Takeda T, Hattori N, Tokuhara T, et al. Adenoviral transduction of MRP-1/CD9 and KAI1/CD82 inhibits lymph node metastasis in orthotopic lung cancer model. Cancer Res 2007;67:1744-9
   PubMed Web of Science ®Google Scholar
• Sun M, Jiang R, Wang G, et al. Cyclin-dependent kinase 2-associated protein 1 suppresses growth and tumorigenesis of lung cancer. Int J Oncol 2013;42:1376-82
   PubMed Web of Science ®Google Scholar
• Abordo-Adesida E, Follenzi A, Barcia C, et al. Stability of lentiviral vector-mediated transgene expression in the brain in the presence of systemic antivector immune responses. Hum Gene Ther 2005;16:741-51
   PubMed Web of Science ®Google Scholar
• Bukrinsky MI, Haffar OK. HIV-1 nuclear import: in search of a leader. Front Biosci 1999;4:D772-81
   PubMedGoogle Scholar
• Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics. Nat Med 2001;7:33-40
   PubMed Web of Science ®Google Scholar
• Hwang SK, Kwon JT, Park SJ, et al. Lentivirus-mediated carboxyl-terminal modulator protein gene transfection via aerosol in lungs of K-ras null mice. Gene Ther 2007;14:1721-30
   PubMed Web of Science ®Google Scholar
• Johnson L, Mercer K, Greenbaum D, et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001;410:1111-16
   PubMed Web of Science ®Google Scholar
• Hwang SK, Lim HT, Minai-Tehrani A, et al. Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice. Am J Respir Crit Care Med 2009;179:1131-40
   PubMed Web of Science ®Google Scholar
• Minai-Tehrani A, Chang SH, Kwon JT, et al. Aerosol delivery of lentivirus-mediated O-glycosylation mutant osteopontin suppresses lung tumorigenesis in K-ras (LA1) mice. Cell Oncol (Dordr) 2013;36:15-26
   Google Scholar
• Shin JY, Hong SH, Kang B, et al. Overexpression of beclin1 induced autophagy and apoptosis in lungs of K-rasLA1 mice. Lung cancer 2013;81:362-70
   PubMed Web of Science ®Google Scholar
• Yu KN, Minai-Tehrani A, Chang SH, et al. Aerosol delivery of small hairpin osteopontin blocks pulmonary metastasis of breast cancer in mice. PLoS One 2010;5:e15623
   Google Scholar
• Hwang SK, Chang SH, Minai-Tehrani A, et al. Lentivirus-AIMP2-DX2 shRNA suppresses cell proliferation by regulating Akt1 signaling pathway in the lungs of AIMP2(+)/(-) mice. J Aerosol Med Pulm Drug Deliv 2013;26:165-73
   PubMed Web of Science ®Google Scholar
• Levine BL, Humeau LM, Boyer J, et al. Gene transfer in humans using a conditionally replicating lentiviral vector. Proc Natl Acad Sci USA 2006;103:17372-7
   PubMed Web of Science ®Google Scholar
• Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 2009;326:818-23
   PubMed Web of Science ®Google Scholar
• Cavazzana-Calvo M, Payen E, Negre O, et al. Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia. Nature 2010;467:318-22
   PubMed Web of Science ®Google Scholar
• Schambach A, Baum C. Clinical application of lentiviral vectors - concepts and practice. Curr Gene Ther 2008;8:474-82
   PubMed Web of Science ®Google Scholar
• Bokhoven M, Stephen SL, Knight S, et al. Insertional gene activation by lentiviral and gammaretroviral vectors. J Virol 2009;83:283-94
   PubMed Web of Science ®Google Scholar
• Kim JM, Shin E, Ryou SM, et al. Gene delivery platforms. Biotechnol Bioprocess Eng 2013;18:637-47
   Web of Science ®Google Scholar
• Miller AD. Progress toward human gene therapy. Blood 1990;76:271-8
   PubMed Web of Science ®Google Scholar
• Crystal RG. Gene therapy strategies for pulmonary disease. Am J Med 1992;92:S44-52
   Google Scholar
• Nusse R, Varmus HE. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Cell 1982;31:99-109
   PubMed Web of Science ®Google Scholar
• Li C, Bowles DE, van Dyke T, et al. Adeno-associated virus vectors: potential applications for cancer gene therapy. Cancer Gene Ther 2005;12:913-25
   PubMed Web of Science ®Google Scholar
• Gao G, Vandenberghe LH, Alvira MR, et al. Clades of adeno-associated viruses are widely disseminated in human tissues. J Virol 2004;78:6381-8
   PubMed Web of Science ®Google Scholar
• Flotte TR, Trapnell BC, Humphries M, et al. Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing α1-antitrypsin: interim results. Hum Gene Ther 2011;22:1239-47
   PubMed Web of Science ®Google Scholar
• Halbert CL, Standaert TA, Wilson CB, et al. Successful readministration of adeno-associated virus vectors to the mouse lung requires transient immunosuppression during the initial exposure. J Virol 1998;72:9795-805
   PubMed Web of Science ®Google Scholar
• Halbert CL, Rutledge EA, Allen JM, et al. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol 2000;74:1524-32
   PubMed Web of Science ®Google Scholar
• Halbert CL, Allen JM, Miller AD. Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol 2001;75:6615-24
   PubMed Web of Science ®Google Scholar
• Weiss DJ, Bonneau L, Allen JM, et al. Perfluorochemical liquid enhances adeno-associated virus-mediated transgene expression in lungs. Mol Ther 2000;2:624-30
   PubMed Web of Science ®Google Scholar
• Halbert CL, Standaert TA, Aitken ML, et al. Transduction by adeno-associated virus vectors in the rabbit airway: efficiency, persistence, and readministration. J Virol 1997;71:5932-41
   PubMed Web of Science ®Google Scholar
• Chang SH, Kim JE, et al. Aerosol delivery of eukaryotic translation initiation factor 4E-binding protein 1 effectively suppresses lung tumorigenesis in K-rasLA1 mice. Cancer Gene Ther 2013;20:331-5
   PubMed Web of Science ®Google Scholar
• DuPage M, Dooley AL, Jacks T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nat protoc 2009;4:1064-72
   PubMed Web of Science ®Google Scholar
• Gierut JJ, Jacks TE, Haigis KM. In vivo delivery of lenti-Cre or adeno-Cre into mice using intranasal instillation. Cold Spring Harb Protoc 2014;2014:307-9
   PubMedGoogle Scholar
• Sené C, Bout A, Imler J-L, et al. Aerosol-mediated delivery of recombinant adenovirus to the airways of nonhuman primates. Hum Gene Ther 1995;6:1587-93
   PubMed Web of Science ®Google Scholar
• Hwang SK, Piao L, Lim HT, et al. Suppression of lung tumorigenesis by leucine zipper/EF hand–containing transmembrane-1. PLoS One 2010;5:e12535
   Google Scholar
• Boussif O, Lezoualc’h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo. Proc Natl Acad Sci USA 1995;92:7297-301
   PubMed Web of Science ®Google Scholar
• Fischer D, Bieber T, Li Y, et al. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999;16:1273-9
   PubMed Web of Science ®Google Scholar
• Marschall P, Malik N, Larin Z. Transfer of YACs up to 2.3 Mb intact into human cells with polyethylenimine. Gene Ther 1999;6:1634-7
   PubMed Web of Science ®Google Scholar
• Ernst N, Ulrichskotter S, Schmalix WA, et al. Interaction of liposomal and polycationic transfection complexes with pulmonary surfactant. J Gene Med 1999;1:331-40
   PubMed Web of Science ®Google Scholar
• Godbey W, Wu KK, Mikos AG. Tracking the intracellular path of poly (ethylenimine)/DNA complexes for gene delivery. Proc Natl Acad Sci USA 1999;96:5177-81
   PubMed Web of Science ®Google Scholar
• Densmore CL, Orson FM, Xu B, et al. Aerosol delivery of robust polyethyleneimine-DNA complexes for gene therapy and genetic immunization. Mol Ther 2000;1:180-8
   PubMed Web of Science ®Google Scholar
• Davies LA, McLachlan G, Sumner-Jones SG. Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol Ther 2008;16:1283-90
   PubMed Web of Science ®Google Scholar
• Gautam A, Densmore CL, Xu B, et al. Enhanced gene expression in mouse lung after PEI–DNA aerosol delivery. Mol Ther 2000;2:63-70
   PubMed Web of Science ®Google Scholar
• Gautam A, Densmore CL, Melton S, et al. Aerosol delivery of PEI–p53 complexes inhibits B16-F10 lung metastases through regulation of angiogenesis. Cancer Gene Ther 2002;9:28-36
   PubMed Web of Science ®Google Scholar
• Gautam A, Densmore CL, Waldrep JC. Inhibition of experimental lung metastasis by aerosol delivery of PEI–p53 complexes. Mol Ther 2000;2:318-23
   PubMed Web of Science ®Google Scholar
• Densmore CL, Kleinerman ES, Gautam A, et al. Growth suppression of established human osteosarcoma lung metastases in mice by aerosol gene therapy with PEI–p53 complexes. Cancer Gene Ther 2001;8:619-27
   PubMed Web of Science ®Google Scholar
• Jia SF, Worth LL, Densmore CL, et al. Aerosol gene therapy with PEI IL-12 eradicates osteosarcoma lung metastases. Clin Cancer Res 2003;9:3462-8
   PubMed Web of Science ®Google Scholar
• Zamora-Avila D, Zapata-Benavides P, Franco-Molina M, et al. WT1 gene silencing by aerosol delivery of PEI–RNAi complexes inhibits B16-F10 lung metastases growth. Cancer Gene Ther 2009;16:892-9
   PubMed Web of Science ®Google Scholar
• Jere D, Jiang H, Arote R, et al. Degradable polyethylenimines as DNA and small interfering RNA carriers. Expert Opin Drug Deliv 2009;6:827-34
   PubMed Web of Science ®Google Scholar
• Kim HW, Park IK, Cho CS, et al. Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 2004;64:7971-6
   PubMed Web of Science ®Google Scholar
• Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J Biol Chem 1998;273:13375-8
   PubMed Web of Science ®Google Scholar
• Yamada KM, Araki M. Tumor suppressor PTEN: modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 2001;114:2375-82
   PubMed Web of Science ®Google Scholar
• Hwang SK, Jin H, Kwon JT, et al. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther 2007;14:1353-61
   PubMed Web of Science ®Google Scholar
• Yang HS, Jansen AP, Komar AA, et al. The transformation suppressor Pdcd4 is a novel eukaryotic initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 2003;23:26-37
   PubMed Web of Science ®Google Scholar
• Tehrani AM, Hwang SK, Kim TH, et al. Aerosol delivery of Akt controls protein translation in the lungs of dual luciferase reporter mice. Gene Ther 2007;14:451-8
   PubMed Web of Science ®Google Scholar
• Minai-Tehrani A, Park YC, Hwang SK, et al. Aerosol delivery of kinase-deficient Akt1 attenuates Clara cell injury induced by naphthalene in the lungs of dual luciferase mice. J Vet Sci 2011;12:309-17
   PubMed Web of Science ®Google Scholar
• Park MR, Han KO, Han IK, et al. Degradable polyethylenimine-alt-poly (ethylene glycol) copolymers as novel gene carriers. J Control Release 2005;105:367-80
   PubMed Web of Science ®Google Scholar
• Xu CX, Jere D, Jin H, et al. Poly (ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis. Am J Respir Crit Care Med 2008;178:60-73
   PubMed Web of Science ®Google Scholar
• Köping-Höggård M, Vårum K, Issa M, et al. Improved chitosan-mediated gene delivery based on easily dissociated chitosan polyplexes of highly defined chitosan oligomers. Gene Ther 2004;11:1441-52
   PubMed Web of Science ®Google Scholar
• Jiang HL, Kim YK, Arote R, et al. Chitosan-graft-polyethylenimine as a gene carrier. J Control Release 2007;117:273-80
   PubMed Web of Science ®Google Scholar
• Jere D, Jiang HL, Kim YK, et al. Chitosan-graft-polyethylenimine for Akt1 siRNA delivery to lung cancer cells. Int J Pharm 2009;378:194-200
   PubMed Web of Science ®Google Scholar
• Kwon JT, Jiang HL, Minai-Tehrani A, et al. Gene expression and pulmonary toxicity of chitosan-graft- polyethylenimine as aerosol gene carrier. Iran J Pharm Res 2013;12:281-6
   Web of Science ®Google Scholar
• Jiang HL, Xu CX, Kim YK, et al. The suppression of lung tumorigenesis by aerosol-delivered folate-chitosan-graft-polyethylenimine/Akt1 shRNA complexes through the Akt signaling pathway. Biomaterials 2009;30:5844-52
   PubMed Web of Science ®Google Scholar
• Kim TH, Ihm JE, Choi YJ, et al. Efficient gene delivery by urocanic acid-modified chitosan. J Control Release 2003;93:389-402
   PubMed Web of Science ®Google Scholar
• Pack DW, Putnam D, Langer R. Design of imidazole-containing endosomolytic biopolymers for gene delivery. Biotechnol Bioeng 2000;67:217-23
   PubMed Web of Science ®Google Scholar
• Jin H, Kim TH, Hwang SK, et al. Aerosol delivery of urocanic acid-modified chitosan/programmed cell death 4 complex regulated apoptosis, cell cycle, and angiogenesis in lungs of K-ras null mice. Mol Cancer Ther 2006;5:1041-9
   PubMed Web of Science ®Google Scholar
• Jin H, Xu CX, Kim HW, et al. Urocanic acid-modified chitosan-mediated PTEN delivery via aerosol suppressed lung tumorigenesis in K-ras(LA1) mice. Cancer Gene Ther 2008;15:275-83
   PubMed Web of Science ®Google Scholar
• Allen JC. Biochemistry of the polyamines. Cell Biochem Funct 1983;1:131-40
   PubMed Web of Science ®Google Scholar
• Jiang HL, Lim HT, Kim YK, et al. Chitosan-graft-spermine as a gene carrier in vitro and in vivo. Eur J Pharm Biopharm 2011;77:36-42
   PubMed Web of Science ®Google Scholar
• Jiang HL, Hong SH, Kim YK, et al. Aerosol delivery of spermine-based poly(amino ester)/Akt1 shRNA complexes for lung cancer gene therapy. Int J Pharm 2011;420:256-65
   PubMed Web of Science ®Google Scholar
• Chang SH, Hong SH, Jiang HL, et al. GOLGA2/GM130, cis-Golgi matrix protein, is a novel target of anticancer gene therapy. Mol Ther 2012;20:2052-63
   PubMed Web of Science ®Google Scholar
• Hong SH, Kim JE, Kim YK, et al. Suppression of lung cancer progression by biocompatible glycerol triacrylate-spermine-mediated delivery of shAkt1. Int J Nanomedicine 2012;7:2293-306
   PubMed Web of Science ®Google Scholar
• Mátrai J, Chuah MK, VandenDriessche T. Recent advances in lentiviral vector development and applications. Mol Ther 2010;18:477-90
   PubMed Web of Science ®Google Scholar
• Morimoto E, Inase N, Mlyake S, et al. Adenovirus-mediated suicide gene transfer to small cell lung carcinoma using a tumor-specific promoter. Anticancer Res 2001;21:329-31
   PubMed Web of Science ®Google Scholar
• Dropulić B. Lentiviral vectors: their molecular design, safety, and use in laboratory and preclinical research. Hum Gene Ther 2011;22:649-57
   PubMed Web of Science ®Google Scholar
• Dull T, Zufferey R, Kelly M, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463-71
   PubMed Web of Science ®Google Scholar
• Escors D, Breckpot K. Lentiviral vectors in gene therapy: their current status and future potential. Arch Immunol Ther Exp (Warsz) 2010;58:107-19
   PubMed Web of Science ®Google Scholar
• Wright JF, Qu G, Tang C, et al. Recombinant adeno-associated virus: formulation challenges and strategies for a gene therapy vector. Curr Opin Drug Discov Devel 2003;6:174-8
   PubMed Web of Science ®Google Scholar
• Hareendran S, Balakrishnan B, Sen D, et al. Adeno-associated virus (AAV) vectors in gene therapy: immune challenges and strategies to circumvent them. Rev Med Virol 2013;23:399-413
   PubMed Web of Science ®Google Scholar
• Zaiss AK, Muruve DA. Immunity to adeno-associated virus vectors in animals and humans: a continued challenge. Gene Ther 2008;15:808-16
   PubMed Web of Science ®Google Scholar
• Rogers GL, Martino AT, Aslanidi GV, et al. Innate immune responses to AAV vectors. Front Microbiol 2011;2:194
   PubMed Web of Science ®Google Scholar
• Lee GK, Maheshri N, Kaspar B, et al. PEG conjugation moderately protects adeno-associated viral vectors against antibody neutralization. Biotechnol Bioeng 2005;92:24-34
   PubMed Web of Science ®Google Scholar
• Lochrie MA, Tatsuno GP, Christie B, et al. Mutations on the external surfaces of adeno-associated virus type 2 capsids that affect transduction and neutralization. J Virol 2006;80:821-34
   PubMed Web of Science ®Google Scholar
• Jayandharan GR, Aslanidi G, Martino AT, et al. Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy. Proc Natl Acad Sci USA 2011;108:3743-8
   PubMed Web of Science ®Google Scholar
• Boutin S, Monteilhet V, Veron P, et al. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum Gene Ther 2010;21:704-12
   PubMed Web of Science ®Google Scholar
• Calcedo R, Vandenberghe LH, Gao G, et al. Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses. J Infect Dis 2009;199:381-90
   PubMed Web of Science ®Google Scholar
• Simon RH, Engelhardt JF, Yang Y, et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: toxicity study. Hum Gene Ther 1993;4:771-80
   PubMed Web of Science ®Google Scholar
• Dong J-Y, Wang D, van Ginkel FW, et al. Systematic analysis of repeated gene delivery into animal lungs with a recombinant adenovirus vector. Hum Gene Ther 1996;7:319-31
   PubMed Web of Science ®Google Scholar
• Parks R, Evelegh C, Graham F. Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration. Gene Ther 1999;6:1565-73
   PubMed Web of Science ®Google Scholar
• Parks RJ, Chen L, Anton M, et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 1996;93:13565-70
   PubMed Web of Science ®Google Scholar
• Guma SR, Lee DA, Ling Y, et al. Aerosol interleukin-2 induces natural killer cell proliferation in the lung and combination therapy improves the survival of mice with osteosarcoma lung metastasis. Pediatr Blood Cancer 2014;61:1362-8
   PubMed Web of Science ®Google Scholar
• Parato KA, Senger D, Forsyth PA, et al. Recent progress in the battle between oncolytic viruses and tumours. Nat Rev Cancer 2005;5:965-76
   PubMed Web of Science ®Google Scholar
• Prestwich RJ, Harrington KJ, Pandha HS, et al. Oncolytic viruses: a novel form of immunotherapy. Expert Rev Anticancer Ther 2008;8:1581-8
   PubMed Web of Science ®Google Scholar
• Ogris M, Brunner S, Schüller S, et al. PEGylated DNA/transferrin–PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther 1999;6:595-605
   PubMed Web of Science ®Google Scholar
• Uchida S, Itaka K, Chen Q, et al. PEGylated polyplex with optimized PEG shielding enhances gene introduction in lungs by minimizing inflammatory responses. Mol Ther 2012;20:1196-203
   PubMed Web of Science ®Google Scholar
• Merkel OM, Rubinstein I, Kissel T. siRNA Delivery to the lung: what’s new? Adv Drug Deliv Rev 2014;75C:112-28
   Google Scholar
• Hong SH, Minai-Tehrani A, Chang SH, et al. Knockdown of the sodium-dependent phosphate co-transporter 2b (NPT2b) suppresses lung tumorigenesis. PLoS One 2013;8:e77121
   Google Scholar
• Taratula O, Garbuzenko OB, Chen AM, et al. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA. J Drug Target 2011;19:900-14
   PubMed Web of Science ®Google Scholar